Get started
Author

Acya Bizieux

Observed names: A. Bizieux, Acya Bizeux
ORCID: 0000-0001-8467-7876
Observed ORCID: 0000-0001-8467-7876
OpenAlex ID: A5098958684
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
2025 · Didier Debieuvre, Lionel Falchero, et al. · NEJM Evidence · 23
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis
2025 · K. Amrane, B. Cabarrou, et al. · ESMO Open · 9
PDF
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06–2018 study)
2024 · Lyria Amari, Pascale Tomasini, et al. · Lung Cancer · 7
PDF
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French national real-world cohort
2026 · E. Gobbini, M.H. Diallo, et al. · ESMO Open
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study)
2024 · Mathilde Jacob, Pierre Fournel, et al. · Lung Cancer
Works count: 5
Citation count: 39
H-index: 3
I10-index: 1
Year
Topic
Type